Home › COPD
Pag-aaral pangklinika para sa COPD na nagre-recruit sa U.S.
98 pag-aaral para sa COPD ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Philadelphia, PA22 pag-aaral
- Birmingham, AL18 pag-aaral
- Miami, FL18 pag-aaral
- Boston, MA17 pag-aaral
- Houston, TX15 pag-aaral
- Orlando, FL15 pag-aaral
- Chicago, IL14 pag-aaral
- Pittsburgh, PA13 pag-aaral
- Baltimore, MD13 pag-aaral
- Dallas, TX12 pag-aaral
- New York City, NY11 pag-aaral
- Ann Arbor, MI10 pag-aaral
- Phoenix, AZ9 pag-aaral
- Kansas City, KS9 pag-aaral
- Los Angeles, CA9 pag-aaral
- Winston-Salem, NC9 pag-aaral
- Cleveland, OH8 pag-aaral
- Detroit, MI8 pag-aaral
- Charlotte, NC8 pag-aaral
- Hialeah, FL8 pag-aaral
- Newport Beach, CA8 pag-aaral
- Milwaukee, WI7 pag-aaral
- Denver, CO7 pag-aaral
- Kendall, FL7 pag-aaral
- Durham, NC7 pag-aaral
- Tampa, FL7 pag-aaral
- Columbus, OH7 pag-aaral
- Indianapolis, IN6 pag-aaral
- Nashville, TN6 pag-aaral
- West Palm Beach, FL6 pag-aaral
- Aurora, CO6 pag-aaral
- Scottsdale, AZ5 pag-aaral
- Camden, NJ5 pag-aaral
- Arlington, VA5 pag-aaral
- Minneapolis, MN5 pag-aaral
- San Francisco, CA5 pag-aaral
- Burlington, VT5 pag-aaral
- Jacksonville, FL5 pag-aaral
- Knoxville, TN5 pag-aaral
- Rapid City, SD5 pag-aaral
Ayos sa estado
- Alabama22 pag-aaral
- Arizona16 pag-aaral
- California26 pag-aaral
- Colorado15 pag-aaral
- Connecticut3 pag-aaral
- Florida28 pag-aaral
- Georgia12 pag-aaral
- Idaho4 pag-aaral
- Illinois19 pag-aaral
- Indiana10 pag-aaral
- Iowa6 pag-aaral
- Kansas12 pag-aaral
- Kentucky5 pag-aaral
- Louisiana9 pag-aaral
- Maine3 pag-aaral
- Maryland15 pag-aaral
- Massachusetts25 pag-aaral
- Michigan22 pag-aaral
- Minnesota11 pag-aaral
- Mississippi3 pag-aaral
- Missouri7 pag-aaral
- Montana3 pag-aaral
- Nebraska5 pag-aaral
- Nevada8 pag-aaral
- New Jersey7 pag-aaral
- New York19 pag-aaral
- North Carolina22 pag-aaral
- Ohio16 pag-aaral
- Oklahoma8 pag-aaral
- Oregon6 pag-aaral
- Pennsylvania33 pag-aaral
- South Carolina13 pag-aaral
- South Dakota6 pag-aaral
- Tennessee14 pag-aaral
- Texas25 pag-aaral
- Utah5 pag-aaral
- Vermont5 pag-aaral
- Virginia12 pag-aaral
- Washington5 pag-aaral
- West Virginia5 pag-aaral
- Wisconsin8 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
Nagre-recruit
Edad 40 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05934565A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07780656: Vascular Function in Health and Disease
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT02966665A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
Nagre-recruitPhase 2
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07725939A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Nagre-recruitPhase 2
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Nagre-recruitPhase 4
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07190209A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Nagre-recruit
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Nagre-recruitPhase 2
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07646587Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07190222Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
Nagre-recruitPhase 4
Edad 60 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07816835A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06883305COPD Exacerbation Follow Up
Nagre-recruitObservasyonal na pag-aaral
Edad 40 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07118306A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06603246The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 40 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Nagre-recruitPhase 2/3
Edad 35 hanggang 80 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07363694Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction
Nagre-recruit
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05257681Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07037836Rademikibart IV for Acute Asthma and COPD Exacerbation
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07705737Photon-counting CT in Chest Imaging
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07031336Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.